{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T21:53:46Z","timestamp":1789509226148,"version":"build-2803163510"},"reference-count":131,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2021,5,4]],"date-time":"2021-05-04T00:00:00Z","timestamp":1620086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,5,4]],"date-time":"2021-05-04T00:00:00Z","timestamp":1620086400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hum Hypertens"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1038\/s41371-021-00540-5","type":"journal-article","created":{"date-parts":[[2021,5,4]],"date-time":"2021-05-04T12:04:09Z","timestamp":1620129849000},"page":"958-969","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Role of hypertension in kidney transplant recipients"],"prefix":"10.1038","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6387-4176","authenticated-orcid":false,"given":"Charalampos","family":"Loutradis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9174-4018","authenticated-orcid":false,"given":"Pantelis","family":"Sarafidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Smaragdi","family":"Marinaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Berry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Borrows","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adnan","family":"Sharif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0577-7081","authenticated-orcid":false,"given":"Charles J.","family":"Ferro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,4]]},"reference":[{"key":"540_CR1","unstructured":"U.S. Renal Data System. USRDS 2019 Annual Data Report: Atlas of End-Stage Renal Disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases: Bethseda, MD, 2019."},{"key":"540_CR2","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1093\/bmb\/ldt012","volume":"106","author":"MJ Bottomley","year":"2013","unstructured":"Bottomley MJ, Harden PN. Update on the long-term complications of renal transplantation. Br Med Bull. 2013;106:117\u201334.","journal-title":"Br Med Bull"},{"key":"540_CR3","doi-asserted-by":"publisher","first-page":"183","DOI":"10.5500\/wjt.v5.i4.183","volume":"5","author":"J Neale","year":"2015","unstructured":"Neale J, Smith AC. Cardiovascular risk factors following renal transplant. World J Transplant. 2015;5:183\u201395.","journal-title":"World J Transplant"},{"key":"540_CR4","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1038\/ki.2014.335","volume":"87","author":"A Hart","year":"2015","unstructured":"Hart A, Weir MR, Kasiske BL. Cardiovascular risk assessment in kidney transplantation. Kidney Int. 2015;87:527\u201334.","journal-title":"Kidney Int"},{"key":"540_CR5","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1159\/000495081","volume":"48","author":"AA Awan","year":"2018","unstructured":"Awan AA, Niu J, Pan JS, Erickson KF, Mandayam S, Winkelmayer WC, et al. Trends in the causes of death among kidney transplant recipients in the united states (1996\u20132014). Am J Nephrol. 2018;48:472\u201381.","journal-title":"Am J Nephrol"},{"key":"540_CR6","doi-asserted-by":"publisher","first-page":"2887","DOI":"10.1681\/ASN.2020050566","volume":"31","author":"T Ying","year":"2020","unstructured":"Ying T, Shi B, Kelly PJ, Pilmore H, Clayton PA, Chadban SJ. Death after kidney transplantation: an analysis by era and time post-transplant. J Am Soc Nephrol. 2020;31:2887\u201399.","journal-title":"J Am Soc Nephrol"},{"key":"540_CR7","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1097\/TP.0b013e3181caeead","volume":"89","author":"H Pilmore","year":"2010","unstructured":"Pilmore H, Dent H, Chang S, McDonald SP, Chadban SJ. Reduction in cardiovascular death after kidney transplantation. Transplantation. 2010;89:851\u20137.","journal-title":"Transplantation"},{"key":"540_CR8","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/0272-6386(93)70098-J","volume":"21","author":"C Ponticelli","year":"1993","unstructured":"Ponticelli C, Montagnino G, Aroldi A, Angelini C, Braga M, Tarantino A. Hypertension after renal transplantation. Am J Kidney Dis. 1993;21:73\u20138.","journal-title":"Am J Kidney Dis"},{"key":"540_CR9","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/S0041-1345(96)00066-8","volume":"29","author":"K Budde","year":"1997","unstructured":"Budde K, Waiser J, Fritsche L, Zitzmann J, Schreiber M, Kunz R, et al. Hypertension in patients after renal transplantation. Transpl Proc. 1997;29:209\u201311.","journal-title":"Transpl Proc"},{"key":"540_CR10","doi-asserted-by":"publisher","first-page":"iii62","DOI":"10.1093\/ndt\/gfh1018","volume":"19","author":"JM Campistol","year":"2004","unstructured":"Campistol JM, Romero R, Paul J, Gutierrez-Dalmau A. Epidemiology of arterial hypertension in renal transplant patients: changes over the last decade. Nephrol Dial Transplant. 2004;19:iii62\u20136.","journal-title":"Nephrol Dial Transplant"},{"key":"540_CR11","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1053\/j.ajkd.2004.03.013","volume":"43","author":"BL Kasiske","year":"2004","unstructured":"Kasiske BL, Anjum S, Shah R, Skogen J, Kandaswamy C, Danielson B, et al. Hypertension after kidney transplantation. Am J Kidney Dis. 2004;43:1071\u201381.","journal-title":"Am J Kidney Dis"},{"key":"540_CR12","doi-asserted-by":"publisher","first-page":"e127","DOI":"10.1016\/j.jacc.2017.11.006","volume":"71","author":"PK Whelton","year":"2018","unstructured":"Whelton PK, Carey RM, Aronow WS, Casey DE, Jr., Collins KJ, Dennison Himmelfarb C. et al. ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the american college of cardiology\/american heart association task force on clinical practice guidelines. J Am Coll Cardiol. 2018;71:e127\u2013e248.","journal-title":"J Am Coll Cardiol"},{"key":"540_CR13","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","volume":"39","author":"B Williams","year":"2018","unstructured":"Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M. et al. ESC\/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018;39:3021\u2013104.","journal-title":"Eur Heart J"},{"key":"540_CR14","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1161\/HYPERTENSIONAHA.120.15026","volume":"75","author":"T Unger","year":"2020","unstructured":"Unger T, Borghi C, Charchar F, Khan NA, Poulter NR, Prabhakaran D. et al. International society of hypertension global hypertension practice guidelines. Hypertension. 2020;75:1334\u201357.","journal-title":"Hypertension"},{"key":"540_CR15","doi-asserted-by":"publisher","first-page":"ii1","DOI":"10.1136\/heartjnl-2014-305693","volume":"100","author":"J. B. S. Board.","year":"2014","unstructured":"J. B. S. Board. Joint British Societies\u2019 consensus recommendations for the prevention of cardiovascular disease (JBS3). Heart. 2014;100:ii1\u2013ii67.","journal-title":"Heart"},{"key":"540_CR16","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1001\/jama.2013.284427","volume":"311","author":"PA James","year":"2014","unstructured":"James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J. et al. Evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA . 2014;311:507\u201320.","journal-title":"JAMA"},{"key":"540_CR17","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/kisup.2012.46","volume":"2","author":"Kidney Disease: Improving Global Outcomes (KDIGO) Blood Pressure Work Group.","year":"2012","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) Blood Pressure Work Group. KDIGO clinical practice guideline for the management of blood pressure in chronic kidney disease. Kidney Int Suppl. 2012;2:337\u2013414.","journal-title":"Kidney Int Suppl"},{"key":"540_CR18","unstructured":"National Institute for Health and Care Excellence. Hypertension in adults: diagnosis and management. https:\/\/www.nice.org.uk\/guidance\/ng136. 2019."},{"key":"540_CR19","unstructured":"National Institute for Health and Care Excellence. Chronic kidney disease in adults: assessment and management. www.nice.org.uk\/guidance\/cg182. 2014."},{"key":"540_CR20","unstructured":"National Heart Foundation of Australia. Guideline for the diagnosis and management of hypertension in adults. https:\/\/www.heartfoundation.org.au\/getmedia\/c83511ab-835a-4fcf-96f5-88d770582ddc\/PRO-167_Hypertension-guideline-2016_WEB.pdf. 2016."},{"key":"540_CR21","doi-asserted-by":"publisher","first-page":"2132","DOI":"10.1016\/j.transproceed.2009.06.078","volume":"41","author":"M Gago Fraile","year":"2009","unstructured":"Gago Fraile M, Fernandez Fresnedo G, Gomez-Alamillo C, de Castro SS, Arias M. Clinical and epidemiological characteristics of refractory hypertension in renal transplant patients. Transpl Proc. 2009;41:2132\u20133.","journal-title":"Transpl Proc"},{"key":"540_CR22","doi-asserted-by":"publisher","first-page":"e11870","DOI":"10.1097\/MD.0000000000011870","volume":"97","author":"A Kolonko","year":"2018","unstructured":"Kolonko A, Bartmanska M, Slabiak-Blaz N, Kuczera P, Kujawa-Szewieczek A, Ficek R, et al. Arterial stiffness but not endothelial dysfunction is associated with multidrug antihypertensive therapy and nondipper blood pressure pattern in kidney transplant recipients. Med (Baltim). 2018;97:e11870.","journal-title":"Med (Baltim)"},{"key":"540_CR23","doi-asserted-by":"publisher","first-page":"iv36","DOI":"10.1093\/ndt\/gfs481","volume":"27","author":"M Arias","year":"2012","unstructured":"Arias M, Fernandez-Fresnedo G, Gago M, Rodrigo E, Gomez-Alamillo C, Toyos C. et al. Clinical characteristics of resistant hypertension in renal transplant patients. Nephrol Dial Transplant. 2012;27:iv36\u20138.","journal-title":"Nephrol Dial Transplant"},{"key":"540_CR24","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1046\/j.1523-1755.1998.00744.x","volume":"53","author":"G Opelz","year":"1998","unstructured":"Opelz G, Wujciak T, Ritz E. Association of chronic kidney graft failure with recipient blood pressure. Collaborative transplant study. Kidney Int. 1998;53:217\u201322.","journal-title":"Kidney Int"},{"key":"540_CR25","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1053\/ajkd.2001.24518","volume":"37","author":"JP Kooman","year":"2001","unstructured":"Kooman JP, Christiaans MH, Boots JM, van Der Sande FM, Leunissen KM, van Hooff JP. A comparison between office and ambulatory blood pressure measurements in renal transplant patients with chronic transplant nephropathy. Am J Kidney Dis. 2001;37:1170\u20136.","journal-title":"Am J Kidney Dis"},{"key":"540_CR26","doi-asserted-by":"publisher","first-page":"E465","DOI":"10.1111\/ctr.12009.","volume":"26","author":"KC Wen","year":"2012","unstructured":"Wen KC, Gourishankar S. Evaluating the utility of ambulatory blood pressure monitoring in kidney transplant recipients. Clin Transplant. 2012;26:E465\u201370.","journal-title":"Clin Transplant"},{"key":"540_CR27","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1111\/jch.12448","volume":"17","author":"J Ahmed","year":"2015","unstructured":"Ahmed J, Ozorio V, Farrant M, Van Der Merwe W. Ambulatory vs office blood pressure monitoring in renal transplant recipients. J Clin Hypertens (Greenwich). 2015;17:46\u201350.","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"540_CR28","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1097\/TP.0000000000001023","volume":"100","author":"F Mallamaci","year":"2016","unstructured":"Mallamaci F, Tripepi R, Leonardis D, Mafrica A, Versace MC, Provenzano F, et al. Nocturnal hypertension and altered night-day BP profile and atherosclerosis in renal transplant patients. Transplantation .2016;100:2211\u20138.","journal-title":"Transplantation"},{"key":"540_CR29","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.1016\/j.transproceed.2012.09.037","volume":"44","author":"G Fernandez Fresnedo","year":"2012","unstructured":"Fernandez Fresnedo G, Franco Esteve A, Gomez Huertas E, Cabello Chaves V, Diz Gomez JM, Osorio Moratalla JM, et al. Ambulatory blood pressure monitoring in kidney transplant patients: RETENAL study. Transpl Proc. 2012;44:2601\u20132.","journal-title":"Transpl Proc"},{"key":"540_CR30","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3109\/08037051.2013.796688","volume":"23","author":"M Kayrak","year":"2014","unstructured":"Kayrak M, Gul EE, Kaya C, Solak Y, Turkmen K, Yazici R, et al. Masked hypertension in renal transplant recipients. Blood Press. 2014;23:47\u201353.","journal-title":"Blood Press"},{"key":"540_CR31","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1038\/ki.1995.162","volume":"47","author":"FG Cosio","year":"1995","unstructured":"Cosio FG, Dillon JJ, Falkenhain ME, Tesi RJ, Henry ML, Elkhammas EA, et al. Racial differences in renal allograft survival: the role of systemic hypertension. Kidney Int. 1995;47:1136\u201341.","journal-title":"Kidney Int"},{"key":"540_CR32","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1001\/jama.283.5.633","volume":"283","author":"KC Mange","year":"2000","unstructured":"Mange KC, Cizman B, Joffe M, Feldman HI. Arterial hypertension and renal allograft survival. JAMA. 2000;283:633\u20138.","journal-title":"JAMA"},{"key":"540_CR33","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1681\/ASN.V1341084","volume":"13","author":"C Rigatto","year":"2002","unstructured":"Rigatto C, Parfrey P, Foley R, Negrijn C, Tribula C, Jeffery J. Congestive heart failure in renal transplant recipients: risk factors, outcomes, and relationship with ischemic heart disease. J Am Soc Nephrol. 2002;13:1084\u201390.","journal-title":"J Am Soc Nephrol"},{"key":"540_CR34","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1097\/01.ASN.0000104574.04006.08","volume":"15","author":"KC Mange","year":"2004","unstructured":"Mange KC, Feldman HI, Joffe MM, Fa K, Bloom RD. Blood pressure and the survival of renal allografts from living donors. J Am Soc Nephrol. 2004;15:187\u201393.","journal-title":"J Am Soc Nephrol"},{"key":"540_CR35","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1111\/j.1399-0012.2004.00235.x","volume":"18","author":"S Aakhus","year":"2004","unstructured":"Aakhus S, Dahl K, Wideroe TE. Cardiovascular disease in stable renal transplant patients in Norway: morbidity and mortality during a 5-yr follow-up. Clin Transplant. 2004;18:596\u2013604.","journal-title":"Clin Transplant"},{"key":"540_CR36","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1111\/j.1399-0012.2004.00315.x","volume":"19","author":"VK Tutone","year":"2005","unstructured":"Tutone VK, Mark PB, Stewart GA, Tan CC, Rodger RS, Geddes CC, et al. Hypertension, antihypertensive agents and outcomes following renal transplantation. Clin Transplant. 2005;19:181\u201392.","journal-title":"Clin Transplant"},{"key":"540_CR37","doi-asserted-by":"publisher","first-page":"2725","DOI":"10.1111\/j.1600-6143.2005.01093.x","volume":"5","author":"G Opelz","year":"2005","unstructured":"Opelz G, Dohler B.Collaborative Transplant S. Improved long-term outcomes after renal transplantation associated with blood pressure control. Am J Transplant. 2005;5:2725\u201331.","journal-title":"Am J Transplant"},{"key":"540_CR38","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1093\/ndt\/gfr587","volume":"27","author":"M Ibernon","year":"2012","unstructured":"Ibernon M, Moreso F, Sarrias X, Sarrias M, Grinyo JM, Fernandez-Real JM, et al. Reverse dipper pattern of blood pressure at 3 months is associated with inflammation and outcome after renal transplantation. Nephrol Dial Transplant. 2012;27:2089\u201395.","journal-title":"Nephrol Dial Transplant"},{"key":"540_CR39","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jash.2010.11.004","volume":"5","author":"HM Wadei","year":"2011","unstructured":"Wadei HM, Amer H, Griffin MD, Taler SJ, Stegall MD, Textor SC. Abnormal circadian blood pressure pattern 1-year after kidney transplantation is associated with subsequent lower glomerular filtration rate in recipients without rejection. J Am Soc Hypertens. 2011;5:39\u201347.","journal-title":"J Am Soc Hypertens"},{"key":"540_CR40","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1097\/HJH.0000000000001530","volume":"36","author":"F Mallamaci","year":"2018","unstructured":"Mallamaci F, D\u2019Arrigo G, Tripepi R, Leonardis D, Porto G, Testa A, et al. Office, standardized and 24-h ambulatory blood pressure and renal function loss in renal transplant patients. J Hypertens. 2018;36:119\u201325.","journal-title":"J Hypertens"},{"key":"540_CR41","doi-asserted-by":"publisher","first-page":"e181","DOI":"10.1136\/bmj.e181","volume":"344","author":"RJ McManus","year":"2012","unstructured":"McManus RJ, Caulfield M, Williams B, National Institute for H. Clinical E. NICE hypertension guideline 2011: evidence based evolution. BMJ .2012;344:e181.","journal-title":"BMJ"},{"key":"540_CR42","doi-asserted-by":"publisher","first-page":"778","DOI":"10.7326\/M15-2223","volume":"163","author":"AL Siu","year":"2015","unstructured":"Siu AL, USPST Force. Screening for high blood pressure in adults: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2015;163:778\u201386.","journal-title":"Ann Intern Med"},{"key":"540_CR43","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1111\/j.1600-6143.2009.02653.x","volume":"9","author":"F Mallamaci","year":"2009","unstructured":"Mallamaci F, Leonardis D, Tripepi R, Parlongo G, Catalano C, Tripepi G, et al. Sleep disordered breathing in renal transplant patients. Am J Transplant. 2009;9:1373\u201381.","journal-title":"Am J Transplant"},{"key":"540_CR44","doi-asserted-by":"publisher","first-page":"125","DOI":"10.2215\/CJN.04030609","volume":"5","author":"MZ Molnar","year":"2010","unstructured":"Molnar MZ, Lazar AS, Lindner A, Fornadi K, Czira ME, Dunai A, et al. Sleep apnea is associated with cardiovascular risk factors among kidney transplant patients. Clin J Am Soc Nephrol. 2010;5:125\u201332.","journal-title":"Clin J Am Soc Nephrol"},{"key":"540_CR45","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-015-0340-5","volume":"13","author":"JA Lafranca","year":"2015","unstructured":"Lafranca JA, IJ JN, Betjes MG, et al. mass index and outcome in renal transplant recipients: a systematic review and meta-analysis. BMC Med. 2015;13:111.","journal-title":"BMC Med"},{"key":"540_CR46","doi-asserted-by":"crossref","unstructured":"Mourad G, Glyda M, Albano L, Viklicky O, Merville P, Tyden G, et al. Incidence of posttransplantation diabetes mellitus in de novo kidney transplant recipients receiving prolonged-release tacrolimus-based immunosuppression with 2 different corticosteroid minimization strategies: ADVANCE, a randomized controlled trial. Transplantation. 2017;101:1924\u201334.","DOI":"10.1097\/TP.0000000000001453"},{"key":"540_CR47","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1681\/ASN.2014080834","volume":"26","author":"MR Weir","year":"2015","unstructured":"Weir MR, Burgess ED, Cooper JE, Fenves AZ, Goldsmith D, McKay D, et al. Assessment and management of hypertension in transplant patients. J Am Soc Nephrol. 2015;26:1248\u201360.","journal-title":"J Am Soc Nephrol"},{"key":"540_CR48","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.trre.2018.06.002","volume":"32","author":"F Aziz","year":"2018","unstructured":"Aziz F, Clark D, Garg N, Mandelbrot D, Djamali A. Hypertension guidelines: how do they apply to kidney transplant recipients. Transpl Rev (Orlando). 2018;32:225\u201333.","journal-title":"Transpl Rev (Orlando)"},{"key":"540_CR49","doi-asserted-by":"publisher","first-page":"e016237","DOI":"10.1161\/JAHA.120.016237","volume":"9","author":"F Mallamaci","year":"2020","unstructured":"Mallamaci F, Tripepi R, D\u2019Arrigo G, Panuccio V, Parlongo G, Caridi G, et al. Sleep-disordered breathing and 24-hour ambulatory blood pressure monitoring in renal transplant patients: longitudinal study. J Am Heart Assoc. 2020;9:e016237.","journal-title":"J Am Heart Assoc"},{"key":"540_CR50","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1053\/j.jrn.2019.01.009","volume":"29","author":"B Workeneh","year":"2019","unstructured":"Workeneh B, Moore LW, Nolte Fong JV, Shypailo R, Gaber AO, Mitch WE. Successful kidney transplantation is associated with weight gain from truncal obesity and insulin resistance. J Ren Nutr. 2019;29:548\u201355.","journal-title":"J Ren Nutr"},{"key":"540_CR51","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1111\/tri.12112","volume":"26","author":"M Hornum","year":"2013","unstructured":"Hornum M, Lindahl JP, von Zur-Muhlen B, Jenssen T, Feldt-Rasmussen B. Diagnosis, management and treatment of glucometabolic disorders emerging after kidney transplantation: a position statement from the Nordic Transplantation Societies. Transpl Int. 2013;26:1049\u201360.","journal-title":"Transpl Int"},{"key":"540_CR52","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1136\/hrt.2009.184879","volume":"96","author":"CD Chue","year":"2010","unstructured":"Chue CD, Townend JN, Steeds RP, Ferro CJ. Arterial stiffness in chronic kidney disease: causes and consequences. Heart. 2010;96:817\u201323.","journal-title":"Heart"},{"key":"540_CR53","doi-asserted-by":"crossref","unstructured":"Moody WE, Edwards NC, Madhani M, Chue CD, Steeds RP, Ferro CJ, et al. Endothelial dysfunction and cardiovascular disease in early-stage chronic kidney disease: cause or association? Atherosclerosis. 2012;223:86\u201394.","DOI":"10.1016\/j.atherosclerosis.2012.01.043"},{"key":"540_CR54","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.2215\/CJN.01190211","volume":"6","author":"JM Yabu","year":"2011","unstructured":"Yabu JM, Winkelmayer WC. Posttransplantation anemia: mechanisms and management. Clin J Am Soc Nephrol. 2011;6:1794\u2013801.","journal-title":"Clin J Am Soc Nephrol"},{"key":"540_CR55","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1053\/j.ajkd.2018.12.044","volume":"74","author":"E Ku","year":"2019","unstructured":"Ku E, Lee BJ, Wei J, Weir MR. Hypertension in CKD: core curriculum 2019. Am J Kidney Dis. 2019;74:120\u201331.","journal-title":"Am J Kidney Dis"},{"key":"540_CR56","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1159\/000313363","volume":"31","author":"HM Siragy","year":"2010","unstructured":"Siragy HM, Carey RM. Role of the intrarenal renin-angiotensin-aldosterone system in chronic kidney disease. Am J Nephrol. 2010;31:541\u201350.","journal-title":"Am J Nephrol"},{"key":"540_CR57","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1016\/j.kint.2019.06.017","volume":"96","author":"AL Faucon","year":"2019","unstructured":"Faucon AL, Flamant M, Metzger M, Boffa JJ, Haymann JP, Houillier P, et al. Extracellular fluid volume is associated with incident end-stage kidney disease and mortality in patients with chronic kidney disease. Kidney Int. 2019;96:1020\u20139.","journal-title":"Kidney Int"},{"key":"540_CR58","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1097\/TP.0000000000000066","volume":"98","author":"W Chan","year":"2014","unstructured":"Chan W, Bosch JA, Jones D, McTernan PG, Inston N, Moore S, et al. Hypervolemia and blood pressure in prevalent kidney transplant recipients. Transplantation .2014;98:320\u20137.","journal-title":"Transplantation"},{"key":"540_CR59","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1111\/j.1523-1755.2004.00552.x","volume":"65","author":"J Neumann","year":"2004","unstructured":"Neumann J, Ligtenberg G, Klein II, Koomans HA, Blankestijn PJ. Sympathetic hyperactivity in chronic kidney disease: pathogenesis, clinical relevance, and treatment. Kidney Int. 2004;65:1568\u201376.","journal-title":"Kidney Int"},{"key":"540_CR60","doi-asserted-by":"crossref","unstructured":"Kaur J, Young BE, Fadel PJ. Sympathetic overactivity in chronic kidney disease: consequences and mechanisms. Int J Mol Sci. 2017;18:1682\u201399.","DOI":"10.3390\/ijms18081682"},{"key":"540_CR61","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1097\/00007890-198711000-00009","volume":"44","author":"BL Kasiske","year":"1987","unstructured":"Kasiske BL. Possible causes and consequences of hypertension in stable renal transplant patients. Transplantation.1987;44:639\u201343.","journal-title":"Transplantation"},{"key":"540_CR62","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1056\/NEJM197007302830502","volume":"283","author":"AF Gazdar","year":"1970","unstructured":"Gazdar AF, Dammin GJ. Neural degeneration and regeneration in human renal transplants. N. Engl J Med. 1970;283:222\u20134.","journal-title":"N. Engl J Med"},{"key":"540_CR63","doi-asserted-by":"publisher","first-page":"1928","DOI":"10.1097\/HJH.0b013e32833c20eb","volume":"28","author":"IH Klein","year":"2010","unstructured":"Klein IH, Abrahams AC, van Ede T, Oey PL, Ligtenberg G, Blankestijn PJ. Differential effects of acute and sustained cyclosporine and tacrolimus on sympathetic nerve activity. J Hypertens. 2010;28:1928\u201334.","journal-title":"J Hypertens"},{"key":"540_CR64","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1093\/ndt\/gfm133","volume":"22","author":"MS Joy","year":"2007","unstructured":"Joy MS, Hogan SL, Thompson BD, Finn WF, Nickeleit V. Cytochrome P450 3A5 expression in the kidneys of patients with calcineurin inhibitor nephrotoxicity. Nephrol Dial Transplant. 2007;22:1963\u20138.","journal-title":"Nephrol Dial Transplant"},{"key":"540_CR65","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1681\/ASN.2004100882","volume":"16","author":"IA Hauser","year":"2005","unstructured":"Hauser IA, Schaeffeler E, Gauer S, Scheuermann EH, Wegner B, Gossmann J, et al. ABCB1 genotype of the donor but not of the recipient is a major risk factor for cyclosporine-related nephrotoxicity after renal transplantation. J Am Soc Nephrol. 2005;16:1501\u201311.","journal-title":"J Am Soc Nephrol"},{"key":"540_CR66","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1097\/FPC.0b013e328328d4e9","volume":"19","author":"O Grisk","year":"2009","unstructured":"Grisk O, Steinbach AC, Ciecholewski S, Schluter T, Kloting I, Schmidt H, et al. Multidrug resistance-related protein 2 genotype of the donor affects kidney graft function. Pharmacogenet Genomics. 2009;19:276\u201388.","journal-title":"Pharmacogenet Genomics"},{"key":"540_CR67","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1111\/j.1600-6143.2011.03513.x","volume":"11","author":"AM Reeves-Daniel","year":"2011","unstructured":"Reeves-Daniel AM, DePalma JA, Bleyer AJ, Rocco MV, Murea M, Adams PL, et al. The APOL1 gene and allograft survival after kidney transplantation. Am J Transplant. 2011;11:1025\u201330.","journal-title":"Am J Transplant"},{"key":"540_CR68","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/0272-6386(93)70097-I","volume":"21","author":"BM Brenner","year":"1993","unstructured":"Brenner BM, Milford EL. Nephron underdosing: a programmed cause of chronic renal allograft failure. Am J Kidney Dis. 1993;21:66\u201372.","journal-title":"Am J Kidney Dis"},{"key":"540_CR69","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1039\/b907021d","volume":"6","author":"RH Barton","year":"2010","unstructured":"Barton RH, Waterman D, Bonner FW, Holmes E, Clarke R, Procardis C, et al. The influence of EDTA and citrate anticoagulant addition to human plasma on information recovery from NMR-based metabolic profiling studies. Mol Biosyst. 2010;6:215\u201324.","journal-title":"Mol Biosyst"},{"key":"540_CR70","unstructured":"Gjertson DW. Explainable variation in renal transplant outcomes: a comparison of standard and expanded criteria donors. Clin Transpl. 2004;189:303\u201314."},{"key":"540_CR71","doi-asserted-by":"publisher","first-page":"2579","DOI":"10.1016\/j.transproceed.2012.09.086","volume":"44","author":"L Blanca","year":"2012","unstructured":"Blanca L, Jimenez T, Cabello M, Sola E, Gutierrez C, Burgos D, et al. Cardiovascular risk in recipients with kidney transplants from expanded criteria donors. Transpl Proc. 2012;44:2579\u201381.","journal-title":"Transpl Proc"},{"key":"540_CR72","doi-asserted-by":"publisher","first-page":"2216","DOI":"10.1016\/j.clinthera.2017.09.011","volume":"39","author":"JB Rice","year":"2017","unstructured":"Rice JB, White AG, Scarpati LM, Wan G, Nelson WW. Long-term systemic corticosteroid exposure: a systematic literature review. Clin Ther. 2017;39:2216\u201329.","journal-title":"Clin Ther"},{"key":"540_CR73","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1681\/ASN.2008040410","volume":"19","author":"M Baum","year":"2008","unstructured":"Baum M, Moe OW. Glucocorticoid-mediated hypertension: does the vascular smooth muscle hold all the answers? J Am Soc Nephrol. 2008;19:1251\u20133.","journal-title":"J Am Soc Nephrol"},{"key":"540_CR74","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1046\/j.1440-1681.2000.03354.x","volume":"27","author":"C Wen","year":"2000","unstructured":"Wen C, Li M, Whitworth JA. Role of nitric oxide in adrenocorticotrophin-induced hypertension: L-arginine effects reversed by N-nitro-L-arginine. Clin Exp Pharm Physiol. 2000;27:887\u201390.","journal-title":"Clin Exp Pharm Physiol"},{"key":"540_CR75","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1291\/hypres.19.1","volume":"19","author":"T Saruta","year":"1996","unstructured":"Saruta T. Mechanism of glucocorticoid-induced hypertension. Hypertens Res. 1996;19:1\u20138.","journal-title":"Hypertens Res"},{"key":"540_CR76","first-page":"123","volume":"5","author":"JJ Curtis","year":"1976","unstructured":"Curtis JJ, Galla JH, Kotchen TA, Lucas B, McRoberts JW, Luke RG. Prevalence of hypertension in a renal transplant population on alternate-day steroid therapy. Clin Nephrol. 1976;5:123\u20137.","journal-title":"Clin Nephrol"},{"key":"540_CR77","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1159\/000180750","volume":"17","author":"FD McDonald","year":"1976","unstructured":"McDonald FD, Horensten ML, Mayor GB, Turcotte JG, Selezinka W, Schork MA. Effect of alternate-day steroids on renal transplant function. A controlled study. Nephron. 1976;17:415\u201329.","journal-title":"Nephron"},{"key":"540_CR78","doi-asserted-by":"publisher","first-page":"381s","DOI":"10.1042\/cs061381s","volume":"61","author":"SH Jackson","year":"1981","unstructured":"Jackson SH, Beevers DG, Myers K. Does long-term low-dose corticosteroid therapy cause hypertension?. Clin Sci (Lond). 1981;61:381s\u20133s.","journal-title":"Clin Sci (Lond)"},{"key":"540_CR79","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1093\/ndt\/gfr374","volume":"27","author":"J Pascual","year":"2012","unstructured":"Pascual J, Royuela A, Galeano C, Crespo M, Zamora J. Very early steroid withdrawal or complete avoidance for kidney transplant recipients: a systematic review. Nephrol Dial Transplant. 2012;27:825\u201332.","journal-title":"Nephrol Dial Transplant"},{"key":"540_CR80","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1358\/dnp.2003.16.5.829315","volume":"16","author":"MM Hamawy","year":"2003","unstructured":"Hamawy MM. Molecular actions of calcineurin inhibitors. Drug N. Perspect. 2003;16:277\u201382.","journal-title":"Drug N. Perspect"},{"key":"540_CR81","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/S0022-5223(19)36181-1","volume":"94","author":"WH Frist","year":"1987","unstructured":"Frist WH, Stinson EB, Oyer PE, Baldwin JC, Shumway NE. Long-term hemodynamic results after cardiac transplantation. J Thorac Cardiovasc Surg. 1987;94:685\u201393.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"540_CR82","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1093\/ajh\/4.5.468","volume":"4","author":"RG Luke","year":"1991","unstructured":"Luke RG. Mechanism of cyclosporine-induced hypertension. Am J Hypertens. 1991;4:468\u201371.","journal-title":"Am J Hypertens"},{"key":"540_CR83","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1097\/00007890-199207000-00009","volume":"54","author":"N Perico","year":"1992","unstructured":"Perico N, Ruggenenti P, Gaspari F, Mosconi L, Benigni A, Amuchastegui CS, et al. Daily renal hypoperfusion induced by cyclosporine in patients with renal transplantation. Transplantation .1992;54:56\u201360.","journal-title":"Transplantation"},{"key":"540_CR84","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/BF00863455","volume":"10","author":"L Dello Strologo","year":"1996","unstructured":"Dello Strologo L, Massella L, Rizzoni G. Cyclosporine-induced transient renal hypoperfusion in adolescent transplant recipients. Pediatr Nephrol. 1996;10:81\u20133.","journal-title":"Pediatr Nephrol"},{"key":"540_CR85","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1038\/ki.1996.183","volume":"49","author":"N Perico","year":"1996","unstructured":"Perico N, Detcheva A, Khalil EI, Remuzzi G. Cyclosporine induces glomerulosclerosis: three-dimensional definition of the lesions in a rat model of renal transplant. Kidney Int. 1996;49:1283\u20138.","journal-title":"Kidney Int"},{"key":"540_CR86","doi-asserted-by":"publisher","first-page":"2244","DOI":"10.1172\/JCI117222","volume":"93","author":"JB Roullet","year":"1994","unstructured":"Roullet JB, Xue H, McCarron DA, Holcomb S, Bennett WM. Vascular mechanisms of cyclosporin-induced hypertension in the rat. J Clin Invest 1994;93:2244\u201350.","journal-title":"J Clin Invest"},{"key":"540_CR87","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1034\/j.1600-6143.2002.20902.x","volume":"2","author":"LW Miller","year":"2002","unstructured":"Miller LW. Cardiovascular toxicities of immunosuppressive agents. Am J Transplant. 2002;2:807\u201318.","journal-title":"Am J Transplant"},{"key":"540_CR88","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1038\/sj.bjp.0705659","volume":"141","author":"SM Gardiner","year":"2004","unstructured":"Gardiner SM, March JE, Kemp PA, Fallgren B, Bennett T. Regional haemodynamic effects of cyclosporine A, tacrolimus and sirolimus in conscious rats. Br J Pharmacol. 2004;141:634\u201343.","journal-title":"Br J Pharmacol"},{"key":"540_CR89","doi-asserted-by":"publisher","first-page":"2810","DOI":"10.1093\/ndt\/gfm390","volume":"22","author":"C Esteva-Font","year":"2007","unstructured":"Esteva-Font C, Ars E, Guillen-Gomez E, Campistol JM, Sanz L, Jimenez W, et al. Ciclosporin-induced hypertension is associated with increased sodium transporter of the loop of Henle (NKCC2). Nephrol Dial Transplant. 2007;22:2810\u20136.","journal-title":"Nephrol Dial Transplant"},{"key":"540_CR90","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1097\/HJH.0b013e32835165e4","volume":"30","author":"EJ Hoorn","year":"2012","unstructured":"Hoorn EJ, Walsh SB, Unwin RJ, Ellison DH. Hypertension after kidney transplantation: calcineurin inhibitors increase salt-sensitivity. J Hypertens. 2012;30:832\u20133.","journal-title":"J Hypertens"},{"key":"540_CR91","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1038\/nm.2497","volume":"17","author":"EJ Hoorn","year":"2011","unstructured":"Hoorn EJ, Walsh SB, McCormick JA, Furstenberg A, Yang CL, Roeschel T, et al. The calcineurin inhibitor tacrolimus activates the renal sodium chloride cotransporter to cause hypertension. Nat Med. 2011;17:1304\u20139.","journal-title":"Nat Med"},{"key":"540_CR92","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1046\/j.1523-1755.2002.00407.x","volume":"62","author":"CJ Ferro","year":"2002","unstructured":"Ferro CJ, Savage T, Pinder SJ, Tomson CR. Central aortic pressure augmentation in stable renal transplant recipients. Kidney Int. 2002;62:166\u201371.","journal-title":"Kidney Int"},{"key":"540_CR93","doi-asserted-by":"publisher","first-page":"S296","DOI":"10.1681\/ASN.2006080930","volume":"17","author":"JM Morales","year":"2006","unstructured":"Morales JM, Dominguez-Gil B. Impact of tacrolimus and mycophenolate mofetil combination on cardiovascular risk profile after kidney transplantation. J Am Soc Nephrol. 2006;17:S296\u2013303.","journal-title":"J Am Soc Nephrol"},{"key":"540_CR94","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.1093\/ndt\/gfn004","volume":"23","author":"BK Kramer","year":"2008","unstructured":"Kramer BK, Del Castillo D, Margreiter R, Sperschneider H, Olbricht CJ, Ortuno J, et al. Efficacy and safety of tacrolimus compared with ciclosporin A in renal transplantation: three-year observational results. Nephrol Dial Transplant. 2008;23:2386\u201392.","journal-title":"Nephrol Dial Transplant"},{"key":"540_CR95","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/S0140-6736(02)07875-3","volume":"359","author":"R Margreiter","year":"2002","unstructured":"Margreiter R. European Tacrolimus vs Ciclosporin Microemulsion Renal Transplantation Study G. Efficacy and safety of tacrolimus compared with ciclosporin microemulsion in renal transplantation: a randomised multicentre study. Lancet .2002;359:741\u20136.","journal-title":"Lancet"},{"key":"540_CR96","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1111\/j.1432-2277.2011.01265.x","volume":"24","author":"F Seibert","year":"2011","unstructured":"Seibert F, Behrendt C, Schmidt S, van der Giet M, Zidek W, Westhoff TH. Differential effects of cyclosporine and tacrolimus on arterial function. Transpl Int. 2011;24:708\u201315.","journal-title":"Transpl Int"},{"key":"540_CR97","doi-asserted-by":"publisher","first-page":"181","DOI":"10.2337\/dc11-1230","volume":"35","author":"L Ghisdal","year":"2012","unstructured":"Ghisdal L, Van Laecke S, Abramowicz MJ, Vanholder R, Abramowicz D. New-onset diabetes after renal transplantation: risk assessment and management. Diabetes Care. 2012;35:181\u20138.","journal-title":"Diabetes Care"},{"key":"540_CR98","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1093\/ndt\/gfr238","volume":"27","author":"K Claes","year":"2012","unstructured":"Claes K, Meier-Kriesche HU, Schold JD, Vanrenterghem Y, Halloran PF, Ekberg H. Effect of different immunosuppressive regimens on the evolution of distinct metabolic parameters: evidence from the Symphony study. Nephrol Dial Transplant. 2012;27:850\u20137.","journal-title":"Nephrol Dial Transplant"},{"key":"540_CR99","doi-asserted-by":"publisher","first-page":"2562","DOI":"10.1056\/NEJMoa067411","volume":"357","author":"H Ekberg","year":"2007","unstructured":"Ekberg H, Tedesco-Silva H, Demirbas A, Vitko S, Nashan B, Gurkan A, et al. Reduced exposure to calcineurin inhibitors in renal transplantation. N. Engl J Med. 2007;357:2562\u201375.","journal-title":"N. Engl J Med"},{"key":"540_CR100","doi-asserted-by":"crossref","unstructured":"Masson P, Henderson L, Chapman JR, Craig JC, Webster AC. Belatacept for kidney transplant recipients. Cochrane Database Syst Rev. 2014; CD010699","DOI":"10.1002\/14651858.CD010699.pub2"},{"key":"540_CR101","doi-asserted-by":"crossref","unstructured":"Morales JM. Influence of the new immunosuppressive combinations on arterial hypertension after renal transplantation. Kidney Int Suppl. 2002;62:S81\u201387.","DOI":"10.1046\/j.1523-1755.62.s82.16.x"},{"key":"540_CR102","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1053\/ajkd.1998.v31.pm9428466","volume":"31","author":"FC Fervenza","year":"1998","unstructured":"Fervenza FC, Lafayette RA, Alfrey EJ, Petersen J. Renal artery stenosis in kidney transplants. Am J Kidney Dis. 1998;31:142\u20138.","journal-title":"Am J Kidney Dis"},{"key":"540_CR103","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1055\/s-2004-861560","volume":"21","author":"DK Rajan","year":"2004","unstructured":"Rajan DK, Stavropoulos SW, Shlansky-Goldberg RD. Management of transplant renal artery stenosis. Semin Interv Radiol. 2004;21:259\u201369.","journal-title":"Semin Interv Radiol"},{"key":"540_CR104","unstructured":"Baird DP, Williams J, Petrie M, James JR. Transplant Renal Artery Stenosis. KI Reports. In press."},{"key":"540_CR105","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1007\/s00270-015-1134-z","volume":"38","author":"AT Ngo","year":"2015","unstructured":"Ngo AT, Markar SR, De Lijster MS, Duncan N, Taube D, Hamady MS. A systematic review of outcomes following percutaneous transluminal angioplasty and stenting in the treatment of transplant renal artery stenosis. Cardiovasc Interv Radiol. 2015;38:1573\u201388.","journal-title":"Cardiovasc Interv Radiol"},{"key":"540_CR106","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1034\/j.1399-0012.1999.130412.x","volume":"13","author":"BN Becker","year":"1999","unstructured":"Becker BN, Odorico JS, Becker YT, Leverson G, McDermott JC, Grist T, et al. Peripheral vascular disease and renal transplant artery stenosis: a reappraisal of transplant renovascular disease. Clin Transplant. 1999;13:349\u201355.","journal-title":"Clin Transplant"},{"key":"540_CR107","doi-asserted-by":"publisher","first-page":"2567","DOI":"10.1111\/ajt.12397","volume":"13","author":"M Giral","year":"2013","unstructured":"Giral M, Foucher Y, Dufay A, Van Huyen JP, Renaudin K, Moreau A, et al. Pretransplant sensitization against angiotensin II type 1 receptor is a risk factor for acute rejection and graft loss. Am J Transplant. 2013;13:2567\u201376.","journal-title":"Am J Transplant"},{"key":"540_CR108","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1056\/NEJMoa035717","volume":"352","author":"D Dragun","year":"2005","unstructured":"Dragun D, Muller DN, Brasen JH, Fritsche L, Nieminen-Kelha M, Dechend R, et al. Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection. N. Engl J Med. 2005;352:558\u201369.","journal-title":"N. Engl J Med"},{"key":"540_CR109","doi-asserted-by":"publisher","first-page":"e57","DOI":"10.1097\/TP.0b013e318234b337","volume":"92","author":"R Kelsch","year":"2011","unstructured":"Kelsch R, Everding AS, Kuwertz-Broking E, Brand E, Spriewald BM, Sibrowski W, et al. Accelerated kidney transplant rejection and hypertensive encephalopathy in a pediatric patient associated with antibodies against angiotensin type 1 receptor and HLA class II. Transplantation. 2011;92:e57\u201359.","journal-title":"Transplantation"},{"key":"540_CR110","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1136\/hrt.2009.192104","volume":"97","author":"F Wei","year":"2011","unstructured":"Wei F, Jia XJ, Yu SQ, Gu Y, Wang L, Guo XM, et al. Candesartan versus imidapril in hypertension: a randomised study to assess effects of anti-AT1 receptor autoantibodies. Heart. 2011;97:479\u201384.","journal-title":"Heart"},{"key":"540_CR111","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1111\/j.1432-2277.2011.01242.x","volume":"24","author":"C Ponticelli","year":"2011","unstructured":"Ponticelli C, Cucchiari D, Graziani G. Hypertension in kidney transplant recipients. Transpl Int. 2011;24:523\u201333.","journal-title":"Transpl Int"},{"key":"540_CR112","first-page":"1","volume":"3","author":"KDIGO CKD Work Group.","year":"2012","unstructured":"KDIGO CKD Work Group. KDIGO clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int. 2012;3:1\u2013150.","journal-title":"Kidney Int"},{"key":"540_CR113","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1097\/TP.0000000000002969","volume":"104","author":"K Kuningas","year":"2020","unstructured":"Kuningas K, Driscoll J, Mair R, Smith H, Dutton M, Day E, et al. Comparing glycaemic benefits of active versus passive lifestyle intervention in kidney allograft recipients: a randomized controlled trial. Transplantation. 2020;104:1491\u20139.","journal-title":"Transplantation"},{"key":"540_CR114","first-page":"1469","volume":"5","author":"G Grzesk","year":"2012","unstructured":"Grzesk G, Wicinski M, Malinowski B, Grzesk E, Manysiak S, Odrowaz-Sypniewska G, et al. Calcium blockers inhibit cyclosporine A-induced hyperreactivity of vascular smooth muscle cells. Mol Med Rep. 2012;5:1469\u201374.","journal-title":"Mol Med Rep"},{"key":"540_CR115","doi-asserted-by":"crossref","unstructured":"Cross NB, Webster AC, Masson P, O\u2019Connell PJ, Craig JC. Antihypertensive treatment for kidney transplant recipients. Cochrane Database Syst Rev. 2009; CD003598.","DOI":"10.1002\/14651858.CD003598.pub2"},{"key":"540_CR116","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1093\/ndt\/gfz092","volume":"35","author":"A Pisano","year":"2020","unstructured":"Pisano A, Bolignano D, Mallamaci F, D\u2019Arrigo G, Halimi JM, Persu A, et al. Comparative effectiveness of different antihypertensive agents in kidney transplantation: a systematic review and meta-analysis. Nephrol Dial Transplant. 2020;35:878\u201387.","journal-title":"Nephrol Dial Transplant"},{"key":"540_CR117","doi-asserted-by":"publisher","first-page":"e000091","DOI":"10.1161\/JAHA.112.000091","volume":"2","author":"W Aftab","year":"2013","unstructured":"Aftab W, Varadarajan P, Rasool S, Kore A, Pai RG. Beta and angiotensin blockades are associated with improved 10-year survival in renal transplant recipients. J Am Heart Assoc. 2013;2:e000091.","journal-title":"J Am Heart Assoc"},{"key":"540_CR118","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3389\/fmed.2020.00229","volume":"7","author":"E Tantisattamo","year":"2020","unstructured":"Tantisattamo E, Molnar MZ, Ho BT, Reddy UG, Dafoe DC, Ichii H, et al. Approach and management of hypertension after kidney transplantation. Front Med (Lausanne). 2020;7:229.","journal-title":"Front Med (Lausanne)"},{"key":"540_CR119","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1159\/000355135","volume":"38","author":"DJ Taber","year":"2013","unstructured":"Taber DJ, Srinivas TM, Pilch NA, Meadows HB, Fleming JN, McGillicuddy JW, et al. Are thiazide diuretics safe and effective antihypertensive therapy in kidney transplant recipients? Am J Nephrol. 2013;38:285\u201391.","journal-title":"Am J Nephrol"},{"key":"540_CR120","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1053\/j.ajkd.2016.12.017","volume":"69","author":"AD Moes","year":"2017","unstructured":"Moes AD, Hesselink DA, van den Meiracker AH, Zietse R, Hoorn EJ. Chlorthalidone versus amlodipine for hypertension in kidney transplant recipients treated with tacrolimus: a randomized crossover trial. Am J Kidney Dis. 2017;69:796\u2013804.","journal-title":"Am J Kidney Dis"},{"key":"540_CR121","doi-asserted-by":"crossref","unstructured":"Bakris GL, Agarwal R, Anker SD, Pitt B, Ruilope LM, Rossing P, et al. Effect of finerenone on chronic kidney disease outcomes in type 2 diabetes. N Engl J Med.\u00a02020;383:2219\u201329.","DOI":"10.1056\/NEJMoa2025845"},{"key":"540_CR122","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1093\/ndt\/gfy407","volume":"34","author":"P Sarafidis","year":"2019","unstructured":"Sarafidis P, Ferro CJ, Morales E, Ortiz A, Malyszko J, Hojs R, et al. SGLT-2 inhibitors and GLP-1 receptor agonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease. A consensus statement by the EURECA-m and the DIABESITY working groups of the ERA-EDTA. Nephrol Dial Transplant. 2019;34:208\u201330.","journal-title":"Nephrol Dial Transplant"},{"key":"540_CR123","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.2337\/dc19-0093","volume":"42","author":"TAS Halden","year":"2019","unstructured":"Halden TAS, Kvitne KE, Midtvedt K, Rajakumar L, Robertsen I, Brox J, et al. Efficacy and safety of empagliflozin in renal transplant recipients with posttransplant diabetes mellitus. Diabetes Care. 2019;42:1067\u201374.","journal-title":"Diabetes Care"},{"key":"540_CR124","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1111\/ajt.15223","volume":"19","author":"E Schwaiger","year":"2019","unstructured":"Schwaiger E, Burghart L, Signorini L, Ristl R, Kopecky C, Tura A, et al. Empagliflozin in posttransplantation diabetes mellitus: a prospective, interventional pilot study on glucose metabolism, fluid volume, and patient safety. Am J Transplant. 2019;19:907\u201319.","journal-title":"Am J Transplant"},{"key":"540_CR125","first-page":"361","volume":"14","author":"G Onesti","year":"1968","unstructured":"Onesti G, Swartz C, Ramirez O, Brest AN. Bilateral nephrectomy for control of hypertension in uremia. Trans Am Soc Artif Intern Organs. 1968;14:361\u20136.","journal-title":"Trans Am Soc Artif Intern Organs"},{"key":"540_CR126","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1136\/bmj.3.5871.78","volume":"3","author":"SL Cohen","year":"1973","unstructured":"Cohen SL. Hypertension in renal transplant recipients: role of bilateral nephrectomy. Br Med J. 1973;3:78\u201381.","journal-title":"Br Med J"},{"key":"540_CR127","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.ijscr.2015.08.001","volume":"15","author":"MJ Lerman","year":"2015","unstructured":"Lerman MJ, Hinton S, Aronoff R. Bilateral native nephrectomy for refractory hypertension in kidney transplant and kidney pancreas transplant patients. Int J Surg Case Rep. 2015;15:127\u20139.","journal-title":"Int J Surg Case Rep"},{"key":"540_CR128","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1007\/s11906-014-0488-y","volume":"16","author":"C Ott","year":"2014","unstructured":"Ott C, Schmieder RE. Invasive treatment of resistant hypertension: present and future. Curr Hypertens Rep. 2014;16:488.","journal-title":"Curr Hypertens Rep"},{"key":"540_CR129","doi-asserted-by":"publisher","first-page":"435","DOI":"10.3949\/ccjm.87a.19099","volume":"87","author":"RD Gajulapalli","year":"2020","unstructured":"Gajulapalli RD, Chahine J, Rader F, Aneja A. Procedures and devices to treat resistant hypertension in chronic kidney disease. Cleve Clin J Med. 2020;87:435\u201343.","journal-title":"Cleve Clin J Med"},{"key":"540_CR130","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1093\/ckj\/sfu134","volume":"8","author":"LC Dobrowolski","year":"2015","unstructured":"Dobrowolski LC, Bemelman FJ, Ten Berge IJ, van den Born BJ, Reekers JA, Krediet CT. Renal denervation of the native kidneys for drug-resistant hypertension after kidney transplantation. Clin Kidney J. 2015;8:79\u201381.","journal-title":"Clin Kidney J"},{"key":"540_CR131","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1093\/ndt\/gfx283","volume":"32","author":"JM Halimi","year":"2017","unstructured":"Halimi JM, Persu A, Sarafidis PA, Burnier M, Abramowicz D, Sautenet B, et al. Optimizing hypertension management in renal transplantation: a call to action. Nephrol Dial Transplant. 2017;32:1959\u201362.","journal-title":"Nephrol Dial Transplant"}],"container-title":["Journal of Human Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41371-021-00540-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41371-021-00540-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41371-021-00540-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T08:06:44Z","timestamp":1675238804000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41371-021-00540-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,4]]},"references-count":131,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["540"],"URL":"https:\/\/doi.org\/10.1038\/s41371-021-00540-5","relation":{},"ISSN":["0950-9240","1476-5527"],"issn-type":[{"value":"0950-9240","type":"print"},{"value":"1476-5527","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,4]]},"assertion":[{"value":"30 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}